How to Help Your Patients Save Money on Sucralfate: A Provider's Guide to Savings Programs

Medication cost is one of the most common barriers to adherence. For sucralfate, a medication that requires four-times-daily dosing for up to 8 weeks, adherence is critical to achieving ulcer healing. Patients who can't afford their prescription — or who don't understand their options — are at significant risk of undertreating their condition. As a provider, a few targeted actions at the point of prescribing can dramatically reduce the cost burden for your patients and improve adherence outcomes.

The Cost Landscape: Where Patients Get Caught

The sucralfate cost landscape is highly variable and often confusing for patients:

• Brand-name Carafate: Can cost $714+ for 120 tablets at retail. Patients with insurance plans that require Carafate specifically (or who receive a brand-specific prescription) may face enormous out-of-pocket costs.
• Generic sucralfate retail: $40–$150 for 60–120 tablets without discounts
• Generic sucralfate with discount card: As low as $4.60–$12 for a 30-day supply with GoodRx — 72–90% off retail
• Oral suspension (200mL): $43+ retail — suspension is more expensive than tablets due to manufacturing complexity

Most patients don't know they can use a discount card independently of insurance, that GoodRx prices sometimes beat insurance copays, or that generic sucralfate is therapeutically equivalent to Carafate. A brief note at the prescribing visit closes these gaps.

Action 1: Prescribe Generic Sucralfate, Not Brand-Name Carafate

This is the single highest-impact action. Writing "sucralfate 1g" with generic substitution allowed ensures patients receive the generic version, saving hundreds of dollars per fill. Brand-name Carafate is not therapeutically superior, and there is no clinical reason to specify it over the generic in routine practice.

If your EHR system has a preference or default for brand-name drugs, check that generic substitution is permitted on the prescription. Some older templates may auto-populate "Carafate" — change this to "sucralfate" with DAW-0 (dispense as written — generic permitted).

Action 2: Recommend Tablets Over Suspension When Clinically Appropriate

The oral suspension is substantially more expensive than tablets — roughly 2–3x per dose — due to manufacturing complexity and fewer generic competitors. For patients who can swallow tablets (which includes most outpatients with peptic ulcer disease or GERD), prescribing the tablet formulation rather than the suspension reduces cost significantly with no loss of efficacy.

Reserve the suspension for patients who have specific clinical indications: difficulty swallowing, NG tube administration, esophageal/pharyngeal applications, or young children.

Action 3: Tell Patients About Discount Cards

Prescription discount cards are free to use and require no registration or approval. Key programs to recommend:

• GoodRx (goodrx.com): As low as $4.60–$12 for a 30-day supply of generic sucralfate. Accepted at over 70,000 US pharmacies.
• SingleCare (singlecare.com): As low as $26.56 for 120 tablets of generic sucralfate.

Important clinical nuance: discount cards and insurance cannot be combined at the point of sale. Advise patients to check the GoodRx price for their specific pharmacy before assuming insurance is cheaper — for low-cost generics like sucralfate, GoodRx sometimes beats even a Tier 1 insurance copay.

Action 4: Prescribe 90-Day Supplies for Maintenance Patients

For patients on maintenance sucralfate (1g twice daily to prevent ulcer recurrence), a 90-day prescription typically reduces the per-unit cost, reduces pharmacy trips, and improves adherence. Insurance plans and mail-order pharmacies often offer better pricing on 90-day fills. Patients with Medicare Part D are well-positioned to use mail-order — the maximum $2,100 annual out-of-pocket cap in 2026 further limits their exposure for covered drugs.

Action 5: Formulary Considerations

Generic sucralfate is typically listed as Tier 1 or Tier 2 on most private insurance and Medicare Part D formularies, with modest copays of $0–$40 per fill. Prior authorization is generally not required for the generic. However, coverage for the brand-name Carafate or the oral suspension may be more restricted. If a patient is denied coverage or facing high cost-sharing, submitting a prior authorization request or requesting a formulary exception may be worthwhile.

What About Patient Assistance Programs (PAPs)?

No manufacturer-sponsored patient assistance programs are currently available for sucralfate. Because generic sucralfate is already accessible at $4.60–$12/month with discount cards, the market has not driven formal PAP programs. For truly uninsured, low-income patients who need additional assistance, consider:

• State pharmaceutical assistance programs (SPAPs) — many states offer medication help for low-income or elderly residents
• Community health centers with 340B pricing — federally qualified health centers and certain hospitals purchase drugs at significantly reduced 340B prices, which benefits low-income patients
• NeedyMeds.org — maintains a database of drug assistance programs and can flag any state or independent programs that cover sucralfate

A Provider Checklist at the Point of Prescribing

• Prescribe generic sucralfate (not Carafate) with generic substitution allowed
• Prescribe tablet form unless suspension is clinically required
• Tell patients to check GoodRx.com for prices before filling — as low as $4.60
• For maintenance patients, write a 90-day prescription
• If patients can't find it in stock, refer them to medfinder.com

For more on helping patients access sucralfate, see our provider guide on how to help your patients find sucralfate in stock. And to recommend a pharmacy search tool to your patients, point them to medfinder for providers.